Synchrogenix, Certara’s Regulatory Writing Consultancy, and CISCRP Partner to Help Biopharm Companies Meet Clinical Data Transparency Requirements
Business News
PRINCETON, N.J.--(BUSINESS WIRE)--Certara® and CISCRP today announced that they are partnering to produce high-quality lay summaries of clinical trials for pharmaceutical companies to share with the general public.
Certara_CMYK.jpg
Read more
< Prev
Next >